Rose SL - Search Results

1

DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage.

Watts GS, Futscher BW, Holtan N, Degeest K, Domann FE, Rose SL. Watts GS, et al. Among authors: rose sl. BMC Med Genomics. 2008 Sep 30;1:47. doi: 10.1186/1755-8794-1-47. BMC Med Genomics. 2008. PMID: 18826610 Free PMC article.

2

Epigenetic regulation of maspin expression in human ovarian carcinoma cells.

Rose SL, Fitzgerald MP, White NO, Hitchler MJ, Futscher BW, De Geest K, Domann FE. Rose SL, et al. Gynecol Oncol. 2006 Aug;102(2):319-24. doi: 10.1016/j.ygyno.2005.12.025. Epub 2006 Feb 7. Gynecol Oncol. 2006. PMID: 16457875

3

Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.

Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Alberts DS, et al. Among authors: rose sl. Gynecol Oncol. 2012 Dec;127(3):451-5. doi: 10.1016/j.ygyno.2012.09.008. Epub 2012 Sep 14. Gynecol Oncol. 2012. PMID: 22986144 Free PMC article. Clinical Trial.

4

Notch 1 signaling is active in ovarian cancer.

Rose SL, Kunnimalaiyaan M, Drenzek J, Seiler N. Rose SL, et al. Gynecol Oncol. 2010 Apr;117(1):130-3. doi: 10.1016/j.ygyno.2009.12.003. Epub 2010 Jan 8. Gynecol Oncol. 2010. PMID: 20060575

5

Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.

DiFeo A, Narla G, Hirshfeld J, Camacho-Vanegas O, Narla J, Rose SL, Kalir T, Yao S, Levine A, Birrer MJ, Bonome T, Friedman SL, Buller RE, Martignetti JA. DiFeo A, et al. Among authors: rose sl. Clin Cancer Res. 2006 Jun 15;12(12):3730-9. doi: 10.1158/1078-0432.CCR-06-0054. Clin Cancer Res. 2006. PMID: 16778100

6

The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer.

Goodheart MJ, Ritchie JM, Rose SL, Fruehauf JP, De Young BR, Buller RE. Goodheart MJ, et al. Among authors: rose sl. Clin Cancer Res. 2005 May 15;11(10):3733-42. doi: 10.1158/1078-0432.CCR-04-0056. Clin Cancer Res. 2005. PMID: 15897570

7

Notch signaling pathway in ovarian cancer.

Rose SL. Rose SL. Int J Gynecol Cancer. 2009 May;19(4):564-6. doi: 10.1111/IGC.0b013e3181a12ed2. Int J Gynecol Cancer. 2009. PMID: 19509550

8

BRCA2 alteration is important in clear cell carcinoma of the ovary.

Goodheart MJ, Rose SL, Hattermann-Zogg M, Smith BJ, De Young BR, Buller RE. Goodheart MJ, et al. Among authors: rose sl. Clin Genet. 2009 Aug;76(2):161-7. doi: 10.1111/j.1399-0004.2009.01207.x. Epub 2009 Jul 28. Clin Genet. 2009. PMID: 19656163

9

Increased Notch1 expression is associated with poor overall survival in patients with ovarian cancer.

Alniaimi AN, Demorest-Hayes K, Alexander VM, Seo S, Yang D, Rose S. Alniaimi AN, et al. Int J Gynecol Cancer. 2015 Feb;25(2):208-13. doi: 10.1097/IGC.0000000000000359. Int J Gynecol Cancer. 2015. PMID: 25611897

10

Exploiting fourth-generation synchrotron radiation for enzyme and photoreceptor characterization.

Malla TN, Muniyappan S, Menendez D, Ogukwe F, Dale AN, Clayton JD, Weatherall DD, Karki P, Dangi S, Mandella V, Pacheco AA, Stojković EA, Rose SL, Orlans J, Basu S, de Sanctis D, Schmidt M. Malla TN, et al. Among authors: rose sl. IUCrJ. 2025 Jan 1. doi: 10.1107/S2052252524010868. Online ahead of print. IUCrJ. 2025. PMID: 39575537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters